This round-up features Daiken Biomedical’s Japanese patent, positive effects of probiotic strain Bifidobacterium breve M-16V, Meiji and Albion’s collaborative launch, Asahi-funded study on yeast mannan, and CBD brand CURE’s Japan debut plans.
Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a measure to legalize medical products derived from cannabis, simultaneously emphasizing the country's existing restrictions on the use of other marijuana products.
The CURE BRAND ("CURE" or the "Company"), an international lifestyle brand for the modern CBD consumer, today announced that it has entered into a joint partnership with Hirokazu Yamura, CEO of AJP Co Ltd, to introduce its portfolio of carefully sourced CBD products into retail and e-commerce marketplaces across Asia's fastest-growing market — Japan.